Quick Answer
AVAI BIO, INC. reported R&D Expense of $27.0 thousand for fiscal year 2020.
AVAI BIO, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2020 | $27.0K | — |
| 2019 | $0.00 | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $23.8K | — | — |
| December 31, 2019 | $0.00 | — | — |
| September 30, 2019 | $0.00 | — | — |
| December 31, 2018 | $0.00 | — | — |
| September 30, 2018 | $0.00 | — | — |
- The most recent figure is from AVAI BIO, INC.’s fiscal year 2019 report (Form 10-K), filed with the SEC on August 13, 2020.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: